PPB Registration Exam Subject 1: Pharmacy Legislation in Hong Kong

Correct: Under Section 6 of the Antibiotics Ordinance (Cap. 137) of Hong Kong, the Director of Health is empowered to exempt any substance or any class of persons from the provisions of the Ordinance. This authority must be exercised by notice in the Gazette and may be subject to such conditions as the Director sees fit to specify. This mechanism allows the regulatory framework to adapt to specific scientific, industrial, or public health requirements where the strict prescription-only control of antibiotics may not be appropriate or necessary.

Incorrect: One approach suggests that the Director of Health can grant informal or verbal waivers for non-profit research institutions. This is incorrect because the Antibiotics Ordinance requires a formal notice in the Gazette to effect an exemption. Another approach incorrectly identifies the Pharmacy and Poisons Board as the primary body for granting these specific exemptions; however, the Antibiotics Ordinance specifically vests this power in the Director of Health, distinct from the Board’s functions under the Pharmacy and Poisons Ordinance. A third approach proposes that substances with very low concentrations of antibiotics are automatically exempt under a de minimis rule. This is incorrect as the Ordinance does not provide for automatic exemptions based on concentration; any substance containing an antibiotic remains controlled unless a specific exemption is granted by the Director.

Takeaway: The Director of Health holds the statutory power under the Antibiotics Ordinance to exempt substances or persons from antibiotic controls via a Gazette notice, often subject to specific regulatory conditions.

Correct: Under the Pharmacy and Poisons Ordinance, the registration of premises for an Authorized Seller of Poisons is valid for one year. To maintain legal status, the owner must apply for renewal and pay the statutory fee prescribed in the Regulations before the expiry of the current certificate. This ensures the premises remains listed on the register maintained by the Pharmacy and Poisons Board and allows the continued sale of poisons.

Incorrect: Assuming that the premises registration is automatically renewed upon the renewal of the pharmacist’s personal practicing certificate is incorrect as these are two distinct statutory requirements under Hong Kong law. Suggesting that a grace period of ninety days exists for late payment without loss of Authorized Seller of Poisons status is a misconception; the law requires valid registration for the legal sale of poisons. Claiming that the renewal fee is waived if no changes have been made to the premises layout or management is incorrect, as the statutory fee is a mandatory annual requirement for the maintenance of the registration itself regardless of operational changes.

Takeaway: Authorized Sellers of Poisons must proactively renew their premises registration annually by paying the prescribed statutory fee to the Pharmacy and Poisons Board to avoid the cessation of their legal authority to sell poisons.

Correct: Under the Pharmacy and Poisons Ordinance in Hong Kong, the registration of a New Chemical Entity (NCE) requires a robust risk assessment of its safety, efficacy, and quality. The Pharmacy and Poisons Board typically requires the applicant to submit Certificates of Free Sale (CFS) from at least two recognized regulatory authorities (such as those in the US, UK, Australia, or EU) to demonstrate that the product has been rigorously evaluated and approved in other stringent jurisdictions. This reliance on established international benchmarks ensures that the clinical risks associated with a new molecule are adequately mitigated before it is introduced to the Hong Kong population.

Incorrect: Requiring only a single certificate of free sale from the country of origin coupled with a commitment to local Phase IV monitoring is insufficient for the initial registration of an NCE in Hong Kong, as the regulatory framework demands more extensive international validation to ensure public safety. While manufacturing quality is essential, focusing primarily on local patent registration and Good Manufacturing Practice (GMP) certification does not address the fundamental requirement for clinical safety and efficacy data necessary for NCE approval. Proposing a full de novo review of raw clinical trial data for every NCE is not the standard procedure for the Hong Kong Department of Health; instead, the system is designed to leverage the evaluation reports and approvals already granted by recognized reference regulatory bodies.

Takeaway: The registration of New Chemical Entities in Hong Kong primarily relies on the submission of approvals from at least two recognized international regulatory authorities to validate the product’s safety and efficacy profile.

Correct: Under Regulation 34 of the Pharmacy and Poisons Regulations in Hong Kong, a registered pharmacist may provide an emergency supply of a Part 1 poison at the request of a patient if they are satisfied there is an immediate need and it is impractical to obtain a prescription. The pharmacist must ensure the medication was previously prescribed for the patient, the quantity supplied does not exceed a 3-day dosage (except for specific items like ointments or inhalers where the smallest pack is used), and the transaction is recorded in the prescription book.

Incorrect: Providing a full month’s supply exceeds the statutory 3-day limit for emergency supplies requested by patients, even if intended to ensure continuity of care. Recording the transaction as a standard retail sale is incorrect because emergency supplies of Part 1 poisons must be entered into the prescription book as if a prescription had been presented. Including Dangerous Drugs in an emergency supply protocol is a violation of the Dangerous Drugs Ordinance, as these substances require a physical prescription and cannot be dispensed under the emergency supply provisions of the Pharmacy and Poisons Regulations.

Takeaway: Emergency supplies of Part 1 poisons at a patient’s request are restricted to a 3-day quantity and must be documented in the prescription book to comply with Hong Kong law.

Correct: Under the Dangerous Drugs Ordinance (Cap. 134) of Hong Kong, any person who has a dangerous drug in their possession and discovers it has been lost or stolen must report the matter to the police immediately. Furthermore, the Department of Health (Drug Office) must be notified as soon as practicable. This dual-reporting process is a mandatory legal requirement to prevent the diversion of controlled substances and to ensure that the regulatory authorities can maintain an accurate oversight of the dangerous drug supply chain.

Incorrect: Delaying the notification to conduct a 48-hour internal audit is incorrect because the law requires immediate reporting to the police upon discovery of the loss or theft to facilitate a timely criminal investigation. Waiting until the next routine inspection to report the loss to the Department of Health is a violation of the regulatory requirement for prompt notification and fails to address the immediate risk of drug diversion. Bypassing the police report based on the quantity or wholesale value of the drug is not permitted under Hong Kong law, as all losses or thefts of dangerous drugs must be reported to the police regardless of the amount involved.

Takeaway: Any loss or theft of dangerous drugs must be reported immediately to the police and as soon as practicable to the Department of Health to comply with Hong Kong pharmacy legislation.

Correct: Under the Pharmacy and Poisons Ordinance of Hong Kong, a Listed Seller of Part 2 Poisons (LSP2P) is permitted to sell substances classified under Part 2 of the Poisons List. A fundamental requirement for these sellers is that the poisons must be sold in the original, unopened containers as supplied by the manufacturer or a wholesale dealer. This regulation ensures that the product remains properly labeled and sealed, as these premises do not require the constant supervision of a registered pharmacist to oversee the repackaging or labeling of toxic substances.

Incorrect: Repackaging or breaking bulk containers of Part 2 poisons for individual retail sale is not permitted for Listed Sellers because they lack the professional pharmaceutical supervision necessary to ensure the integrity and correct labeling of the subdivided products. Selling any Part 1 poisons, regardless of whether they are stored in locked cabinets or are non-prescription items, is strictly prohibited for Listed Sellers; such sales are the exclusive domain of Authorized Sellers of Poisons (ASPs). Dispensing medications against a prescription is a professional practice reserved for ASPs under the supervision of a registered pharmacist, and a Listed Seller’s license does not grant the authority to interpret or fulfill medical prescriptions.

Takeaway: Listed Sellers of Part 2 Poisons in Hong Kong are legally restricted to the retail sale of Part 2 substances in their original manufacturer packaging and cannot handle Part 1 poisons or dispense prescriptions.

Correct: Under Section 2 of the Pharmacy and Poisons Ordinance (Cap 138), a poison is defined as any substance specified in the Poisons List. The legal classification is determined strictly by the substance’s inclusion in the Poisons List Regulations (Cap 138A). If a substance is listed, it remains a poison regardless of the manufacturer’s marketing claims, the product’s designation as a health supplement, or the concentration level, unless a specific exemption for a particular concentration or preparation is explicitly detailed within the Poisons List itself.

Incorrect: One approach suggests that the classification depends on whether the product is marketed for a medicinal purpose. This is incorrect because the statutory definition of a poison is independent of the manufacturer’s intended use if the substance is already listed in the Poisons List. Another approach incorrectly applies a general de minimis concentration threshold for all substances; however, under Hong Kong law, exemptions based on concentration are not universal and must be specifically stated for each individual entry in the Schedule. A third approach suggests that the Pharmacy and Poisons Board can grant ad-hoc discretionary exemptions for proprietary products, which is incorrect as the Board must follow the legislative process to amend the Poisons List Regulations to change a substance’s status.

Takeaway: The legal definition of a poison in Hong Kong is strictly tied to its inclusion in the Poisons List under Cap 138, overriding external factors like product labeling or non-specified concentration limits.

Correct: Under Regulation 22(5) of the Pharmacy and Poisons Regulations (Cap. 138A) of Hong Kong, if a prescriber directs that a prescription for a Part 1 poison may be dispensed at stated intervals but fails to specify the total number of times it should be dispensed, the law stipulates that the prescription shall not be dispensed more than three times in total. The pharmacist must ensure that each dispensing event is properly recorded on the prescription and in the relevant registers to maintain legal compliance.

Incorrect: One approach suggests that a prescription is legally invalid if it lacks a specific number of repeats despite having stated intervals; however, the Pharmacy and Poisons Regulations provide a specific default limit for this exact scenario rather than rendering the document void. Another approach suggests dispensing the medication for a duration of one year based on the assumption of chronic maintenance; this is incorrect as the statutory limit of three dispensings takes precedence over clinical assumptions in the absence of a specified count. A third approach suggests that the pharmacist may continue dispensing at the stated intervals indefinitely based on professional discretion; this is a violation of the specific legal cap mandated by the regulations for prescriptions missing a total count.

Takeaway: According to Hong Kong pharmacy legislation, a prescription that specifies intervals but omits the total number of repeats is legally restricted to a maximum of three dispensings.

Correct: Under Regulation 19(2) of the Pharmacy and Poisons Regulations (Cap. 138A), the particulars required to be stated on the label of a container of a poison must be in both the English and Chinese languages. This risk-based approach ensures that the essential information regarding the identity and strength of the medicine is accessible to the entire population of Hong Kong, regardless of their primary language, thereby minimizing the risk of medication errors or accidental poisoning.

Incorrect: Providing the required particulars primarily in English while only translating cautionary warnings into Chinese characters is insufficient, as the regulation mandates that all required particulars, not just warnings, must be bilingual. Using English for chemical names and Chinese for indications is also non-compliant because it fails to provide a complete bilingual record for each required data point on the label. Relying on a supplementary leaflet to provide the Chinese translation while keeping the container label in English only does not satisfy the legal requirement that the particulars must be stated on the label of the container itself to ensure the information is permanently attached to the medicine.

Takeaway: All statutory particulars on the label of a poison container in Hong Kong must be presented in both English and Chinese to ensure regulatory compliance and patient safety.

Correct: Maintaining a dedicated dispensing area of at least 4.5 square meters that is physically separated from the public retail space and equipped with a sink with a supply of potable water. This approach adheres to the Code of Practice for Authorized Sellers of Poisons (ASP) in Hong Kong, which specifies that the dispensing area must be of adequate size, distinct from the general trading area, and provided with essential facilities like a sink to ensure a hygienic environment for preparing medications.

Incorrect: Storing Part I poisons in glass-fronted cabinets within the retail area for inventory visibility is incorrect because the regulations require Part I poisons to be stored in a locked container or a partitioned area that is not accessible to the public. Setting the ambient temperature to 28 degrees Celsius is non-compliant as the standard requirement for general drug storage in Hong Kong is typically 25 degrees Celsius or below to ensure product stability. Integrating the dispensing bench into the main service counter while placing the sink in a separate staff restroom is unacceptable because the dispensing area must be a clearly defined, separate space and the sink must be located within that specific area to facilitate proper pharmaceutical practice.

Takeaway: An ASP must maintain a physically distinct dispensing area of at least 4.5 square meters equipped with its own water supply and strictly controlled storage conditions to meet Hong Kong statutory requirements.

Correct: According to Regulation 5 of the Dangerous Drugs Regulations (Cap. 134A) of Hong Kong, every person required to keep a register must make the entry on the day on which the drug is received or supplied, or if that is not practicable, on the following day. This specific timeline ensures that records are maintained as contemporaneously as possible while allowing a small window for administrative practicalities in a busy pharmacy setting.

Incorrect: Suggesting that entries must be made strictly within 24 hours of the transaction is a common misconception that ignores the specific legal phrasing of the following day. Proposing that entries be consolidated at the end of a business week is a significant regulatory violation, as it exceeds the maximum allowable delay and compromises the integrity of the monitoring system. Requiring entries to be made immediately upon physical handover, while a high standard of practice, is not the specific legal requirement and does not account for the practicability clause provided in the Hong Kong regulations.

Takeaway: Under Hong Kong law, entries in the Dangerous Drugs Register must be made on the day of the transaction or, if not practicable, on the following day.

Correct: Under the Antibiotics Ordinance (Cap. 137) of Hong Kong, a substance to which the Ordinance applies may only be sold by retail if the sale is under a prescription signed by a registered medical practitioner, a registered dentist, or a registered veterinary surgeon. The prescription must be in writing and specify the date on which it was given, the name and address of the person for whose treatment it is given (or the name and address of the owner of the animal if for veterinary use), and the total amount of the substance to be supplied. This protocol ensures that antibiotic substances are dispensed only under the direct authorization of qualified professionals to prevent misuse and address public health concerns regarding antimicrobial resistance.

Incorrect: One approach involves accepting a verbal or telephoned request from a known medical practitioner to expedite the dispensing process, but the Antibiotics Ordinance requires a physical, signed prescription at the time of sale, with no provision for emergency verbal orders for these specific substances. Another approach suggests that registered nurses or midwifes may authorize refills for antibiotics in specific clinical settings to optimize workflow, but these professionals are not listed as authorized prescribers under Cap. 137. A third approach considers the validity of prescriptions issued by registered Chinese medicine practitioners for antibiotic substances to promote integrated medicine, but the current Hong Kong regulatory framework does not grant Chinese medicine practitioners the authority to prescribe substances controlled under the Antibiotics Ordinance.

Takeaway: Legal dispensing of antibiotics in Hong Kong requires a written prescription from a registered medical practitioner, dentist, or veterinary surgeon containing all statutory patient and prescriber details.

Correct: Under the Pharmacy and Poisons Ordinance (Cap. 138), the definition of a pharmaceutical product is based on its function or presentation for treating or preventing disease, or interfering with physiological functions. Even if a substance or its ingredients are not explicitly included in the Poisons List (Schedule 10 of the Pharmacy and Poisons Regulations), the finished product must still be registered with the Pharmacy and Poisons Board of Hong Kong if it meets the statutory definition of a pharmaceutical product. Selling an unregistered pharmaceutical product is an offense, regardless of its poison classification status.

Incorrect: Treating a substance as a general retail commodity solely because it is absent from the Poisons List is incorrect because it fails to account for the mandatory registration of pharmaceutical products under Cap. 138. Assuming a substance can be voluntarily classified as a Part 2 Poison by a pharmacist for safety purposes is a regulatory error, as the power to classify substances into the Poisons List rests solely with the Pharmacy and Poisons Board through legislative amendment. Suggesting that an unlisted substance can be sold if it is labeled as a health supplement ignores the fact that if the product makes medicinal claims or has a medicinal effect, it is legally a pharmaceutical product and requires a registration number (HK-XXXXX) to be sold legally in Hong Kong.

Takeaway: The legal requirement for pharmaceutical product registration in Hong Kong is independent of the substance’s presence on the Poisons List and is determined by the product’s medicinal claims or physiological effects.

Correct: Under Regulation 23 of the Pharmacy and Poisons Regulations (Cap. 138A) of Hong Kong, when an Authorized Seller of Poisons (ASP) ceases to carry on business at any premises, the person who was carrying on the business must notify the Secretary of the Pharmacy and Poisons Board in writing within 14 days of the cessation. The legal disposal of poisons in this context requires transferring the stock to other authorized entities, such as another ASP or a licensed wholesale dealer, to ensure that regulated substances remain within the legal supply chain.

Incorrect: Maintaining poisons at the premises for 90 days while seeking a buyer is incorrect because once a business ceases to operate as an ASP, the legal authority to possess those poisons at that location for the purpose of retail sale ends, and the 14-day notification rule is the priority. Surrendering stocks to the Government Chemist is not the standard regulatory procedure for business termination; the proprietor is responsible for the legal transfer or disposal through commercial channels. While transfers to medical practitioners are permitted under general sales regulations, the specific requirement upon termination of an ASP business emphasizes the notification to the Board and the transfer to authorized traders to ensure the closure is documented and the poisons are accounted for.

Takeaway: Upon the cessation of business, an Authorized Seller of Poisons must notify the Pharmacy and Poisons Board within 14 days and ensure all poison stocks are transferred to authorized persons or entities.

Correct: Under Regulation 11(3) of the Dangerous Drugs Regulations (Cap. 134A) of Hong Kong, a medical practitioner or dentist is strictly prohibited from prescribing a dangerous drug for his or her own use. This statutory restriction is an absolute prohibition designed to ensure that the necessity for controlled substances is independently assessed by another healthcare professional, thereby preventing self-abuse and maintaining objective clinical standards. A pharmacist who dispenses a dangerous drug against a self-prescription would be in violation of the law, as the prescription itself is not legally valid.

Incorrect: Suggesting that the prescription can be dispensed if the quantity is limited to a short-term supply or if the practitioner records it in their own Dangerous Drugs Register is incorrect because the law does not provide any exemptions for quantity or record-keeping in the case of self-prescribing. Proposing that a countersignature from another practitioner validates the self-prescription is also legally flawed; the law requires a separate prescription issued by an independent practitioner rather than an endorsement of an illegal self-prescription. Claiming that a written declaration of clinical necessity allows for dispensing ignores the specific statutory bar in Regulation 11, which overrides general professional autonomy in the context of dangerous drugs.

Takeaway: In Hong Kong, the Dangerous Drugs Regulations strictly prohibit medical practitioners from self-prescribing dangerous drugs, requiring an independent practitioner to issue any such prescription.

Correct: Under the Antibiotics Ordinance (Cap. 137) of Hong Kong, the sale of substances listed in the Schedule, which includes amoxicillin, is strictly prohibited except under a valid prescription from a registered medical practitioner, dentist, or veterinary surgeon. Any person who contravenes this requirement commits an offense and is liable on conviction to a maximum fine at level 4, which is currently set at HK$30,000, and imprisonment for 12 months. This penalty applies to the individual who performed the sale and reflects the high priority the Hong Kong government places on controlling antibiotic resistance and ensuring patient safety through professional oversight.

Incorrect: Suggesting a maximum fine of HK$100,000 and imprisonment for 2 years is incorrect because these specific figures are the maximum penalties associated with the Pharmacy and Poisons Ordinance (Cap. 138) for general offenses involving Part 1 poisons, rather than the specific Antibiotics Ordinance. Proposing a fixed penalty of HK$5,000 and a mandatory 3-month license suspension is inaccurate as the Antibiotics Ordinance is enforced through criminal prosecution in court rather than an administrative fixed-penalty system. Stating a maximum fine of HK$50,000 and a formal reprimand without a prison sentence is incorrect because it misidentifies the statutory fine level and ignores the provision for custodial sentences explicitly stated in Cap. 137.

Takeaway: The unauthorized sale of antibiotics in Hong Kong is a criminal offense under the Antibiotics Ordinance, carrying a maximum penalty of a HK$30,000 fine and 12 months imprisonment.

Correct: According to Regulation 28 of the Pharmacy and Poisons Regulations (Cap. 138A) in Hong Kong, poisons in a retail shop must be stored in one of three specific ways: in a cupboard or drawer reserved solely for the storage of poisons; in a part of the premises which is partitioned off from the remainder of the premises and to which customers are not permitted to have access; or on a shelf reserved solely for the storage of poisons, provided no food is kept directly under that shelf. Storing the Part 2 poisons on a dedicated shelf used exclusively for poisons while ensuring no food items or beverages are stored on any shelves directly beneath it is a legally recognized method for both Authorized Sellers of Poisons and Listed Sellers of Poisons.

Incorrect: Placing poisons in a locked display cabinet within a customer browsing area does not satisfy the requirement for a partitioned area to which customers are not permitted access, as the cabinet itself is located within the public part of the shop. Storing poisons in a drawer that also contains non-poisonous items like dressings or medical devices violates the strict requirement that the drawer must be reserved solely for the storage of poisons. Arranging poisons on a general-purpose shelf behind a counter based on a specific distance separation is incorrect because the law requires the shelf itself to be reserved exclusively for poisons and specifically mandates the absence of food items directly below.

Takeaway: Retailers of Part 2 poisons must ensure storage is either in a reserved, exclusive compartment or on a dedicated shelf that is strictly separated from food products to prevent cross-contamination and unauthorized access.

Correct: Under Section 35 of the Pharmacy and Poisons Ordinance (Cap. 138), an inspector has the authority to seize and remove any substance or article if they have reasonable cause to suspect it is evidence of an offense. This power is essential for enforcement and does not require a separate warrant for each item found during a lawful inspection of an Authorized Seller of Poisons.

Incorrect: Requiring a court warrant for every individual item found during a routine inspection would severely hinder the enforcement of the Ordinance; inspectors are empowered to seize suspected evidence upon discovery. While inspectors have broad powers over the premises and articles, they do not have the legal authority under the Pharmacy and Poisons Ordinance to conduct personal body searches of staff members. The power to take samples for analysis is a statutory right of the inspector and is not contingent upon the pharmacist providing written consent at the time of the inspection.

Takeaway: Inspectors appointed by the Pharmacy and Poisons Board have the statutory authority to seize suspected evidence and take samples without needing specific prior consent or individual warrants for each item during an inspection.

Correct: Retaining the prescription and contacting the prescriber for verification is the standard professional response in Hong Kong when a forgery is suspected. Under the Dangerous Drugs Ordinance (Cap. 134), a pharmacist must not dispense a dangerous drug if they have reason to believe the prescription is not genuine. Retaining the document prevents the individual from attempting to use the forged document at another pharmacy, and notifying the police is necessary when a criminal act like forgery is identified.

Incorrect: Dispensing the original dose while ignoring the alteration is a violation of the Dangerous Drugs Regulations, as any suspicion of forgery invalidates the entire document for dispensing purposes. Returning the prescription to the patient is a failure of professional duty because it allows the suspected forged document to remain in circulation, potentially leading to successful fraud elsewhere. Relying on identity card verification is insufficient because the validity of the prescription depends on the prescriber’s authorization, not just the patient’s identity.

Takeaway: A pharmacist must withhold dispensing and verify the authenticity of any suspicious Dangerous Drug prescription to comply with the Dangerous Drugs Ordinance and prevent the diversion of controlled substances.

Correct: Under the Dangerous Drugs Regulations (Cap. 134A) of Hong Kong, specifically Regulation 14, any person authorized to supply dangerous drugs is prohibited from destroying such drugs unless it is done in the presence of and in accordance with the directions of a person authorized by the Director of Health. This process requires a formal application to the Drug Office of the Department of Health, and the destruction must be documented in the Dangerous Drugs Register, including the date and the signature of the authorized officer witnessing the act.

Incorrect: The approach of destroying drugs in the presence of a second registered pharmacist and a lay witness is incorrect because the law mandates the presence of an official authorized by the Director of Health, not merely professional peer supervision. Returning expired dangerous drugs to a wholesaler for disposal without prior official notification or supervision is inappropriate because the pharmacist remains responsible for the drugs until they are legally destroyed or transferred under specific permits. Denaturing the drugs independently using chemical agents and recording the act with two internal signatures is insufficient as it bypasses the mandatory requirement for an external authorized officer to supervise the destruction process.

Takeaway: Legal disposal of dangerous drugs in Hong Kong requires the physical presence and supervision of an authorized officer from the Department of Health to ensure compliance with the Dangerous Drugs Ordinance.

Correct: The Board must assess the substance based on its toxicity, the potential danger to the public if misused, and the requirement for professional supervision by a registered pharmacist or medical practitioner to ensure safe use. This aligns with the statutory duty to protect public health under the Pharmacy and Poisons Ordinance (Cap. 138), where the primary concern is the safety and welfare of the community rather than commercial interests.

Incorrect: Prioritizing the economic impact on local pharmaceutical manufacturers or market competitiveness is incorrect because the Board’s mandate is public safety, not trade regulation. Delaying classification solely to wait for local clinical trials regarding ethnic sensitivity is not a standard requirement for poison classification if sufficient international safety data indicates a risk to the public. Automatically listing substances based on international classifications without an independent review by the Board’s own committees fails to satisfy the statutory obligation to exercise local regulatory discretion as defined in Hong Kong law.

Takeaway: The inclusion of a substance in the Poisons List is determined by the inherent risks of the substance and the level of professional control required to mitigate those risks for public safety.

Correct: Under Section 5 of the Pharmacy and Poisons Ordinance (Cap. 138) of Hong Kong, the titles pharmacist, pharmaceutical chemist, pharmaceutist, chemist, and druggist are strictly reserved for registered pharmacists. Additionally, Section 5(2) allows a body corporate that is an Authorized Seller of Poisons (ASP) to use these titles if the business is under the bona fide control of a registered pharmacist. Any person or business not meeting these criteria is prohibited from using these titles or any description implying registration under the Ordinance. Therefore, a non-ASP retail outlet must ensure that its business name and all advertisements exclude these restricted terms to remain compliant with the law.

Incorrect: Using the title chemist based on academic qualifications alone is a violation because the Ordinance restricts the title specifically to those registered as pharmacists in Hong Kong, regardless of the owner holding a science degree. Adopting the description pharmaceutical specialist is prohibited because the law forbids any name, title, or description implying that the person or business is registered under the Ordinance or has a professional status they do not possess. The title druggist is specifically listed as a restricted term in Section 5, and its use is prohibited even if a pharmacy technician is employed, as the title is reserved exclusively for registered pharmacists or Authorized Sellers of Poisons.

Takeaway: The Pharmacy and Poisons Ordinance restricts specific professional titles like chemist and druggist to registered pharmacists and Authorized Sellers of Poisons to prevent public deception regarding professional status.

Correct: Under the Pharmacy and Poisons Ordinance and the Code of Practice for Authorized Sellers of Poisons in Hong Kong, the pharmacist-in-charge is legally required to ensure their certificate of registration and name are conspicuously displayed at the registered premises. Furthermore, the law mandates that the sale of Part 1 poisons must be conducted under the personal supervision of a registered pharmacist to ensure public safety and adherence to the regulatory framework.

Incorrect: Allowing a pharmacy assistant to supply Part 1 poisons during a pharmacist’s absence, even with telecommunication availability, fails the legal requirement for personal and physical supervision by a registered pharmacist. Retaining prescription records for five years is an incorrect application of the law, as the Pharmacy and Poisons Regulations specify a retention period of two years for the Poisons Register and related prescriptions. Providing notification of a change in the pharmacist-in-charge within 30 days is a regulatory failure, as Hong Kong legislation requires such changes to be reported to the Pharmacy and Poisons Board within 14 days.

Takeaway: The pharmacist-in-charge must ensure their credentials are visible and that all Part 1 poisons are sold under direct, personal pharmacist supervision as required by Hong Kong law.

Correct: Under Regulation 5 of the Dangerous Drugs Regulations (Cap. 134) of Hong Kong, a person shall not supply a dangerous drug on a prescription unless they are either acquainted with the signature of the prescriber and have no reason to suppose that the prescription is not genuine, or have taken reasonably sufficient steps to satisfy themselves that it is genuine. This impact assessment requires the pharmacist to exercise professional judgment and proactive verification before the drug leaves the pharmacy, as the legal burden of authentication rests on the dispenser to prevent the diversion of controlled substances through forged authorizations.

Incorrect: Suggesting that a pharmacist may dispense the medication first and verify the signature within a 24-hour grace period is incorrect because the law requires satisfaction of the signature’s genuineness as a prerequisite to the act of supplying. Relying solely on the Medical Council of Hong Kong’s online registry is insufficient because, while the registry confirms a practitioner’s registration status, it does not provide signature specimens for comparison or satisfy the requirement to verify the specific handwriting on the document. Assuming that a known patient’s history or the presence of a clinic’s printed details waives the need for signature verification is a regulatory failure, as the Dangerous Drugs Ordinance does not provide exemptions based on patient familiarity or the professional appearance of the stationery.

Takeaway: In Hong Kong, the pharmacist has a mandatory legal obligation to verify the authenticity of an unfamiliar prescriber’s signature through reasonably sufficient steps before dispensing any dangerous drug.

Correct: Under Regulation 11 of the Pharmacy and Poisons Regulations, a registered pharmacist may supply a Part 1 poison (which is not a Dangerous Drug or an Antibiotic) without a prescription if they are satisfied there is an immediate need and the medicine was previously prescribed by a registered practitioner. The quantity must not exceed a 3-day supply, and the transaction must be recorded in the prescription book.

Incorrect: Providing a 7-day supply is incorrect because the legislation strictly limits the emergency supply at a patient’s request to a maximum of 3 days. Supplying an antibiotic for an emergency is prohibited because the Antibiotics Ordinance does not provide a legal exemption for emergency supply to a patient without a valid prescription. Requiring a retrospective prescription within 24 hours is a specific requirement for emergency supplies requested by a medical practitioner, not for those requested directly by a patient.

Takeaway: Emergency supplies at a patient’s request in Hong Kong are limited to a 3-day supply of Part 1 poisons, excluding antibiotics and dangerous drugs, and must be documented in the prescription book.

Correct: Under the Pharmacy and Poisons Regulations (Cap. 138A) of Hong Kong, specifically Regulation 18, it is a mandatory requirement that the label of every container and the outer wrapping of a registered pharmaceutical product must bear both the batch number and the expiry date. This ensures that even if the outer packaging is discarded, the product remains traceable and its safety period is identifiable by the end-user or healthcare professional.

Incorrect: Providing the batch number only on the outer carton while omitting it from the immediate container is a violation of the regulations, as traceability must be maintained at the unit-of-use level. Using internal manufacturer codes that are not clearly legible or identifiable as a batch number fails the requirement for clear labeling intended for public and professional safety. Prioritizing ingredient concentrations over batch and expiry information on smaller containers is legally insufficient, as Hong Kong regulations do not provide a general exemption for these critical traceability markers based on container size.

Takeaway: Hong Kong pharmacy legislation requires the batch number and expiry date to be clearly printed on both the immediate container and the outer packaging of all registered pharmaceutical products.

Correct: The emergence of new evidence indicating that the product’s risks to public health outweigh its therapeutic benefits, or that the product fails to meet established standards of safety, efficacy, or quality. Under the Pharmacy and Poisons Ordinance (Cap. 138) of Hong Kong, the Pharmacy and Poisons Executive Committee (PPEC) is responsible for the continuous monitoring of drug safety. If pharmacovigilance data or new clinical trials suggest that a drug is no longer safe or effective for its intended use, the PPEC has the authority to recommend the suspension or cancellation of its registration to protect public health.

Incorrect: Focusing on market pricing or economic factors is incorrect because the PPEC’s mandate under the Pharmacy and Poisons Ordinance is strictly limited to safety, efficacy, and quality; the Hong Kong regulatory framework does not grant the PPEC powers to regulate drug prices or market competition. Basing decisions on patent expiration is incorrect as patent status is a matter of intellectual property law and does not inherently change the safety or efficacy profile of a registered drug, nor is it a legal ground for registration cancellation by the PPEC. Relying on competitor requests regarding cost-effectiveness is incorrect because the regulatory framework prioritizes objective clinical evidence and public health protection over commercial interests or economic comparisons between different brands.

Takeaway: The PPEC’s authority to recommend deregistration is fundamentally rooted in the ongoing assessment of a drug’s safety, efficacy, and quality relative to public health risks.

Correct: Under Section 13 of the Pharmacy and Poisons Ordinance (Cap. 138) and Regulation 12 of the Pharmacy and Poisons Regulations, an Authorized Seller of Poisons (ASP) is required to display the prescribed logo in a conspicuous position at the premises where the retail business of poisons is conducted. This regulatory requirement ensures that the public can clearly identify the establishment as a legally recognized pharmacy that is under the supervision of a registered pharmacist and authorized to sell poisons.

Incorrect: Displaying the logo exclusively within an internal consultation area or dispensary fails the legal requirement for the logo to be in a conspicuous position, which generally implies visibility to any person approaching or entering the shop. Using the logo on transport vehicles or digital platforms may be part of branding but does not fulfill the statutory obligation to mark the physical premises. Displaying the logo only at a corporate headquarters is insufficient because the Ordinance requires the logo to be present at each individual registered location where the business of an Authorized Seller of Poisons is actually carried out.

Takeaway: Every registered premises of an Authorized Seller of Poisons in Hong Kong must conspicuously display the prescribed logo to signify its legal authorization to the public.

Correct: Under Section 6 of the Antibiotics Ordinance (Cap. 137) of Hong Kong, the Director of Health has the specific statutory power to exempt any substance or preparation from the application of the Ordinance. This is achieved through a formal notice published in the Gazette. Without such a specific gazetted exemption, any substance falling under the definition of an antibiotic must be sold only via a valid prescription issued by a registered medical practitioner, dentist, or veterinary surgeon, regardless of its concentration or intended route of administration.

Incorrect: One approach suggests that the product could be reclassified by the Pharmacy and Poisons Board based on its safety profile. While the Board manages the Pharmacy and Poisons Ordinance, the specific authority to exempt substances from the Antibiotics Ordinance lies with the Director of Health, not the Board. Another approach assumes that low-concentration topical preparations are automatically exempt or fall under different scheduling like Part 2 poisons. This is incorrect because the Antibiotics Ordinance does not provide for automatic exemptions based on concentration; the substance remains controlled until the Director of Health intervenes. A third approach proposes that labeling the product for external use and keeping a sales register would suffice for legal sale. This is a regulatory failure because labeling and record-keeping do not override the fundamental requirement for a prescription for any non-exempted antibiotic.

Takeaway: The Director of Health is the sole authority empowered to exempt antibiotic preparations from the Antibiotics Ordinance via a notice in the Gazette.